Related Experiment Video
Updated: Jan 21, 2026

Acute Myocardial Infarction in Rats
Published on: February 16, 2011
MicroRNA-132 improves myocardial remodeling after myocardial infarction
1Department of Cardiology, the People's Hospital of Rizhao, Rizhao, China. chengxiaojing11@163.com.
Objective:
To elucidate the potential role of microRNA-132 in myocardial infarction (MI) and its underlying mechanism.
Materials And Methods:
The myocardial infarction model was established in WT and microRNA-132 KO mice using the LAD ligation method. WT mice were assigned into the control group (LAD ligation for MI) and sham group. After animal procedures, infarct size was calculated using hematoxylin and eosin (HE) staining and cardiac function was evaluated using echocardiography, respectively. By analyzing differentially expressed microRNAs relative to MI in a microarray, microRNA-132 was screened out and further verified by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). Hemodynamic parameters and cardiac function indexes in mice were accessed, including scar length/LV length, FS, dp/dtmax, dp/dtmin, ESV, EDV, EF and Tau_w.
Results:
QRT-PCR data showed a gradual decrease in microRNA-132 expression in the infarction zone, border zone and remote zone within 7 days after MI. Compared with mice in the control group, microRNA-132 KO mice showed a higher percentage of scar length/LV length at postoperative day 14 and day 28. MicroRNA-132 KO mice showed decreased FS, dp/dtmax and EF, but increased dp/dtmin, ESV and EDV. The injection of different concentrations of microRNA-132 mimics into mice (8 mg/kg, 16 mg/kg and 32 mg/kg) could reduce LVIDD, LVIDs, ESV, EDV, dp/dtmin and Tau_w. However, FS, EF and dp/dtmax increased by the injection of microRNA-132 mimics at postoperative day 28. The injection of 16 mg/kg microRNA-132 mimics significantly reduced the percentage of scar length/LV length in microRNA-132 KO mice than the control group and miR-CO group. After injection of 16 mg/kg microRNA-132 mimics, LVIDD and LVIDs markedly decreased at postoperative day 14 and day 28 compared with the control group and miR-CO group. However, FS was elevated by microRNA-132 mimics.
Conclusions:
MicroRNA-132 is involved in the development of myocardial infarction. The MicroRNA-132 expression is upregulated after myocardial infarction, influencing infarct size and cardiac function.
Insights
MicroRNA-132 plays a crucial role in myocardial infarction (MI) development. Its downregulation exacerbates cardiac dysfunction and infarct size, while its upregulation may offer therapeutic benefits.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- MicroRNA Research
Background:
- MicroRNAs are key regulators of gene expression.
- Myocardial infarction (MI) is a leading cause of mortality worldwide.
- The specific role of microRNA-132 in MI pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate the role of microRNA-132 in myocardial infarction.
- To understand the underlying mechanisms by which microRNA-132 affects cardiac function and infarct size.
Main Methods:
- Established a myocardial infarction model in wild-type (WT) and microRNA-132 knockout (KO) mice.
- Assessed infarct size via histological staining and cardiac function using echocardiography.
- Quantified microRNA-132 expression using quantitative Real-Time Polymerase Chain Reaction (qRT-PCR).
- Administered microRNA-132 mimics to evaluate therapeutic effects.
Main Results:
- MicroRNA-132 expression decreased significantly in the infarcted myocardium post-MI.
- MicroRNA-132 KO mice exhibited worsened cardiac function and increased infarct size.
- Administration of microRNA-132 mimics improved cardiac function and reduced infarct size in a dose-dependent manner.
Conclusions:
- MicroRNA-132 is implicated in the development of myocardial infarction.
- Modulating microRNA-132 levels can impact infarct size and cardiac function post-MI.
- MicroRNA-132 represents a potential therapeutic target for myocardial infarction treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Bone Remodeling
Osteoclasts in Bone Remodeling
Improving Translational Accuracy

